Canadian Virtual Conference on Ovarian Cancer Research (CCOCR) - May 13-14, 2021

Call for Abstracts

All abstracts will be reviewed and considered for short talks (15 min), rapid-fire talks (3 min) and video poster presentations (5-10 min). All presenters of accepted video poster abstracts will be asked to upload a video poster so that participants can view the posters during the 3 days preceding the event.

Notifcation emails were sent on April 15 and we expect your answer by April 22.
If you did not receive the email, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

Important Dates

  • March 1
    Call for Abstracts opens
  • March 19
    Call for Abstracts closes
    This deadline will NOT be extended.
    You must have registered and paid for the event for your abstracts to be included in the review process.
  • April 15
    Notification of acceptance with scheduling details
  • May 1
    Video Poster Submission Deadline
    Short Talks and Rapid-fire Talks PPT presentations due

Abstract Format and Content

  • Abstracts must be written in English.
  • Length of abstract body: max. 2000 characters (with spaces)
  • Title: max. 200 characters (with spaces). Sentence case obligatory.
  • The following abstract subheadings must be used: Introduction, Methods, Results, Conclusions
  • The abstract must be submitted in final form. The body of the abstract may be formatted by the program manager in order to follow the guidelines.
  • Abstracts should be concise and informative and include at least preliminary data. Those stating that results will be presented or discussed may be subject to rejection.
  • Non-standard abbreviations should be placed in parentheses after the full term the first time they appear.
  • The use of trade names and company identification is not permitted.
  • Submissions not conforming to the established guidelines may not be reviewed.

Abstract Categories

  • Genetics and risk factors
  • Improving patient quality of life
  • Addressing the challenges of current treatments (eg. chemoresistance)
  • What we have learned from “omics” approaches
  • Innovations in model systems
  • Cellular plasticity and reprogramming cancer cells
  • Novel treatments / personalized medicine
  • Tumour immunology and immunotherapy
  • Other


IS Event Solutions
T 450-550-3488 ext. 2
F 514-227-5083
E This email address is being protected from spambots. You need JavaScript enabled to view it.